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Abstract: With the aim of evaluating the application of new benzoxazole derivatives as photoactive 
moiety in butyric acid prodrugs, ester conjugates were synthesized by reaction of the 
chloromethylated heterocyclic precursors with the model drug. Photocleavage studies of the 
conjugates in methanol/HEPES buffer (80:20) solutions at different wavelengths of irradiation (254, 
300 and 350 nm) confirmed the quantitative release of the butyric acid in short irradiation times. 
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1. Introdution 
 
Photoremovable protecting groups find application in the photoactivation of organic, small 
inorganic species and ions in several areas including synthesis and bioapplications, namely in 
biochemistry, neurobiology and biomedicine.1 In bioapplications these groups are more especially 
designated as phototriggers. As an extension, the use of an appropriate photolabile group could be 
an alternative to the molecular design of prodrugs, being the reactivity controlled by selecting the 
wavelength of the excitation light. Recent reports enclose the use of photoactive prodrugs in the 
improvement of drug delivery.2-4 
Butyric acid is known to be related to the disruption of cell proliferation and induction of apoptosis; 
modification of cell morphology; and alteration of gene expression.5,6 Nonetheless, poor absorption 
from the gastrointestinal tract due to the presence of a carboxylic acid group is a limitation to be 
circumvent. 
Recent research by the authors includes synthesis and application of novel oxygen and nitrogen 
heterocycles as photolabile groups in the light triggered release of several biological relevant 
compounds, including butyric acid.7-10 With the aim of improving the photophysical properties of 
oxo-benzopyranoxazole derivatives, and consequently the delivery of the drug, three new oxo-
benzopyranoxazoles were synthesised and evaluated as photosensitive moieties. The stability to 
irradiation of the ester bond between butyric acid and the caging group was evaluated in a 
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photochemical reactor at 254, 300 and 350 nm using methanol with aqueous HEPES buffer in 80:20 
solutions with collection of kinetic data. 
 
 
2. Experimental 
 
2.1. Typical procedure for the synthesis of oxo-benzopyranoxazoles 5-7 (described for 5). To a 
solution of 6-amino-4-(chloromethyl)-7-hydroxy-2-oxo-2H-benzopyran 1 (0.095 g, 0.42 mmol) in 
polyphosphoric acid (0.500 g), benzoic acid 3 (2 equiv, 0.101 g, 0.83 mmol) was added, and the 
mixture was stirred at 130 °C for 4 h. The reaction mixture was poured into iced water and stirred 
for 1 h to give a fine grey precipitate. The solid was collected by filtration, washed with cold water 
and dried in a vacuum oven. 8-(Chloromethyl)-2-phenyl-6-oxo-6H-benzopyrano[6,7-d]oxazole 5 
was obtained as a grey solid (0.080 g, 62 %). 1H NMR (400 MHz, DMSO-d6): δ = 5.11 (2H, s, 
CH2), 6.69 (1H, s, H-7), 7.61-7-67 (3H, m, 3×Ar-H), 7.92 (1H, s, H-4), 8.21 (2H, dd, J 7.6 and 1.6 
Hz, 2×Ar-H), 8.28 (1H, s, H-9) ppm. 13C NMR (100.6 MHz, DMSO-d6): δ = 41.47 (CH2), 99.58 
(C-4), 114.13 (C-7), 114.69 (C-8a), 115.46 (C-9), 125.65 (Ar-C), 127.28 (Ar-C), 127.35 (Ar-C), 
129.20 (Ar-C), 132.27 (Ar-C), 138.36 (C-9a), 150.75 (C-8), 151.64 (C-4a), 151.93 (C-3a), 159.03 
(C-6), 163.91 (C-2) ppm. 
 
2.2. Typical procedure for the synthesis of conjugates 8-10 (described for 8). The chloromethyl 
precursor  5 (0.090 g, 0.29 mmol) was dissolved in dry  DMF (3 mL), potassium fluoride (3 equiv, 
0.050 g, 0.86 mmol) and butyric acid (1 equiv, 0.026 mL, 0.29 mmol) were  added.  The reaction 
mixture was stirred at  room  temperature  for  24 h.  The  solvent  was removed  by  evaporation  
under  reduced  pressure  and  the  crude  residue  was  purified  by  column chromatography using 
chloroform/methanol (95:5) as eluent. (6-Oxo-2-phenyl-6H-benzopyrano[6,7-d]oxazol-8-yl)methyl 
butyrate 8 was obtained as a yellow solid (0.050 g, 48 %). 1H NMR (400 MHz, CDCl3): δ = 1.01 
(3H, t, J 7.6 Hz, CH2CH2CH3), 1.73-1.78 (2H, m, CH2CH2CH3), 2.48 (2H, t, J 7.2 Hz, 
CH2CH2CH3), 5.38 (2H, s, CH2), 6.52 (1H, s, H-7), 7.54-7.61 (4H, m, H4 and 3×Ar-H), 7.91 (1H, s, 
H-9), 8.25-8.28 (2H, m, 2×Ar-H) ppm. 13C NMR (100.6 MHz, CDCl3): δ = 13.20 (CH2CH2CH3), 
17.88 (CH2CH2CH3), 35.44 (CH2CH2CH3), 60.74 (CH2), 99.37 (C-4), 111.85 (C-7), 113.51 (C-9), 
114.36 (C-8a), 125.72 (Ar-C), 127.41 (Ar-C), 128.64 (Ar-C), 131.86 (Ar-C), 138.87 (C-9a), 148.99 
(C-8), 151.48 (C-4a), 152.06 (C-3a), 159.79 (C-6), 164.49 (C-2), 172.24 (C=O ester) ppm. 
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2.3. General photolysis procedure 
A 1 × 10-4 M methanol/HEPES buffer (80:20) solution of conjugates 8-10 (5 mL) was placed in a 
quartz tube and irradiated in a Rayonet RPR-100 reactor at the desired wavelength. The lamps used 
for irradiation were of 254, 300, and 350 ± 10 nm.  HEPES buffer solution was prepared in distilled 
water with HEPES (4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid) (10 mM), sodium 
chloride (120 mM), potassium chloride (3 mM), calcium chloride (1 mM) and magnesium chloride 
(1 mM) and pH adjusted to 7.2.  Aliquots of 100 µL were taken at regular intervals and analysed by 
RP-HPLC. The eluent was acetonitrile/water (3:1) at a flow rate of 0.8 mL/min for all compounds, 
previously filtered through a Millipore, type HN 0.45 µm filter and degassed by ultra-sound for 30 
min. The chromatograms were traced by detecting UV absorption at the wavelength of maximum 
absorption (retention time: 6.6 min, 8; 6.5 min, 9; 6.7 min, 10). 
 
 
3. Results and Discussion 
 
Previous work reported by the authors includes the use of fused oxazole systems, namely an oxo-
benzopyranoxazole, as phototriggers in the release of butyric acid.9,10 In order to improve the 
photophysical properties and the photorelease times of the considered drug from this type of 
heterocycles, compounds 5-7 bearing the phenyl ring without substituents and with chlorine atom or 
methyl group, in addition to the amine function, were synthesized.  
The synthesis of these new chloromethylated oxo-benzopyran[6,7-d]oxazoles 5-7 was achieved by a 
condensation reaction between 6-amino-4-(chloromethyl)-7-hydroxy-2-oxo-2H-benzopyrane 19  
and benzoic acid 2, 3-amino-4-chlorobenzoic acid 3 or 3-amino-4-methylbenzoic acid 4 mediated 
by polyphosphoric acid at 130º C according to a known procedure.11 Compounds 5-7 were used in 
the derivatisation of butyric acid in the presence of potassium fluoride in N,N-dimethylformamide at 
room temperature,12 resulting in the ester prodrugs 8-10 in moderate to good yields (Table 1, 
Scheme 1). 
UV-visible spectroscopic characterization was carried out to obtain the required parameters for 
monitoring during photolysis. Absorption and emission spectra of degassed 10-5 M solutions in 
methanol/HEPES buffer (80:20) solution of conjugates 8-10 were measured and the corresponding 
data are presented in Table 1. 
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Scheme 1. Synthesis of oxo-benzopyranoxazoles 5-7 and the corresponding butyric acid conjugates 
8-10.  
 
Relative fluorescence quantum yields (ΦF) were calculated using 9,10-diphenylanthracene in 
ethanol (ΦF 0.95)13 as standard. For the ΦF determination, the fluorescence standard was excited at 
the wavelengths of maximum absorption found for each compound to be tested and in all 
fluorimetric measurements the absorbance of the solution did not exceed 0.1. 
Regarding the maximum absorption wavelengths (λabs) in methanol/HEPES buffer (80:20) solutions 
the new conjugates 8-10 displayed a bathochromic shift from 13 to 19 nm (λabs 339-345 nm) in 
comparison with compound 11, previously obtained by us (Figure 1).9 
The fluorescence spectra in the same solvent revealed that emission maxima (λem) of conjugates 8-
10 occurred in the range 418-456 nm, with relative fluorescent quantum yields inferior to the 
analogue 11, and good Stokes’ shifts (79 -112 nm). 
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Table 1. Yields, UV/visible absorption and fluorescence data for compounds 5-11 in 
methanol/HEPES buffer (80:20) solutions. 
Cpd Yield (%) 
Absorption Fluorescence 
λabs (nm) log ε λem (nm) ΦF Stokes’ shift (nm) 
5 62 341 3.98 397 0.06 56 
6 70 341 3.85 418 0.01 77 
7 54 342 3.46 423 0.02 81 
8 48 339 3.86 418 0.07 79 
9 70 344 3.78 456 0.07 112 
10 69 345 4.04 430 0.01 85 
119 95 326 3.83 424 0.10 98 
 
The release of butyric acid from conjugates 8-10 was carried out by photolysis at different 
wavelengths. Solutions of the mentioned compounds (1 × 10-4 M) in methanol/HEPES buffer 
(80:20) solutions were irradiated in a Rayonet RPR-100 reactor at 254, 300 and 350 nm, in order to 
determine the most favourable cleavage conditions. The course of the photocleavage reactions was 
followed by reverse phase HPLC with UV detection. The determined irradiation time represents the 
time necessary for the consumption of the starting materials until less than 5% of the initial area 
was detected (Table 2). 
 
 
Figure 1. Structure of conjugate 11.9 
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Table 2. Irradiation times (tirr, in min) and k (×10
-2 min-1) for the complete photolysis (95%) of 
compounds 8-11 at different wavelengths in methanol/HEPES buffer (80:20) solutions.  
Compound 
254 nm 300 nm 350 nm 
tirr k tirr k tirr k 
8 13 23.1 46 6.05 55 5.38 
9 58 5.14 195 1.56 193 1.56 
10 35 8.62 127 2.32 160 1.87 
119 45 6.59 33 6.59 285 1.04 
 
The results at various wavelengths of irradiation revealed the significant influence of the aromatic 
substitution on the oxazole ring, at position 2 of the oxo-benzopyranoxazole, in the irradiation time 
(tirr) necessary to release butyric acid (Table 2). In comparison with conjugate 11, bearing a methyl 
group, the most relevant result is related to the decrease of irradiation times at 350 nm, more than 
five times in the case of compound 8 (tirr 55 mim), which is advantageous for biological purposes. 
On the other hand, by comparing conjugates 9 and 10, the presence at the benzene ring of a methyl 
group promotes faster photolysis than chlorine atom in all wavelengths of irradiation. Considering 
practical applications of the present compounds, although they cleaved readily at 254 nm (the 
fastest being 8 with 13 min) and also at 300 nm (the fastest being 8 with 46 min), photolysis at these 
wavelengths can be damaging to biological media. Therefore, photolysis at 350 nm and longer 
wavelengths is always preferable, and encouraged by the obtained results, we will continue the 
development of new oxo-benzopyranoxazoles.  
 
 
4. Conclusions 
 
Three new fluorescent ester conjugates were synthesised in moderated to good yields by a 
straightforward procedure, between chloromethylated oxo-benzopyranoxazole derivatives and 
butyric acid. Evaluation of these conjugates as photoactive prodrugs revealed that quantitative 
release of butyric acid was possible under irradiation at 254, 300 and 350 nm in short irradiation 
times. This preliminary study also suggests that aromatic substitution at the oxazole ring decreased 
the time necessary for delivering the drug. The presence and nature of substituents at phenyl could 
also influence the photolysis of conjugates and future studies will be carried out to clarify these 
effects and increase the conjugation in the aromatic system. 
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